Is Pfizer a Millionaire Maker?
With a market capitalization of more than $143 billion today, Pfizer (NYSE: PFE) stock won't make anyone into a millionaire unless they're willing to commit a large amount of capital and then hold the stock for a very long period of time, reinvesting all the dividends they receive along the way. Big pharma businesses simply don't grow quickly enough to deliver investors the massive returns that are necessary to generate millions from a humble starting sum.
There's no evidence that Pfizer is about to change its business model in a radical way which might challenge that dynamic. Still, it could be a great option for shoring up your portfolio with an asset that generates some solid cash flow and might appreciate a bit in value over time. Here's why.
One of the most obvious ways that a stock can help to boost your portfolio's value is by paying a dividend consistently over time. Pfizer could fill that role quite well, and now's an especially appealing time to invest in it for that purpose.
Source Fool.com
Pfizer Inc. Stock
We see a rather positive sentiment for Pfizer Inc. with 14 Buy predictions and 2 Sell predictions.
As a result the target price of 27 € shows a positive potential of 25.06% compared to the current price of 21.59 € for Pfizer Inc..
